The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00571.x · Cited by 986
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Glass, C. K., Rose, D. W., & Rosenfeld, M. G. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80066-x · Cited by 698
Pietras, R. J., Arboleda, J., Dm, R., Wongvipat, N., Pegram, M. D., Ramos, L., Cm, G., Mg, P., Sliwkowski, M. X., & Dj, S. (1995) · PubMed · Cited by 603
Dopaminergic and Ligand-Independent Activation of Steroid Hormone Receptors
Power, R. F., Mani, S. K., Codina, J., Conneely, O. M., & O'Malley, B. W. (1991) · Science · doi:10.1126/science.1749936 · Cited by 567
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.
Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., & Korach, K. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4658 · Cited by 480
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
Kyprianou, N., English, H. F., & Isaacs, J. T. (1990) · PubMed · Cited by 478
Aronica, S. M. (1993) · Molecular Endocrinology · doi:10.1210/me.7.6.743 · Cited by 456
The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element
Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Brinkmann, A. O., & Trapman, J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1921 · Cited by 451
Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Trapman, J., Brinkmann, A. O., & Mulder, E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90401-4 · Cited by 446
Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-402 · Cited by 399
Self-citationThe Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Raitano, A. B., Halpern, J. R., Hambuch, T. M., & Sawyers, C. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11746 · Cited by 394
Self-citationJanknecht, R., & Hunter, T. (1996) · Nature · doi:10.1038/383022a0 · Cited by 393
Cleutjens, K. B. J. M., van der Korput, H. A. G. M., van Eekelen, C. C. E. M., van Rooij, H. C. J., Faber, P. W., & Trapman, J. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9883 · Cited by 374
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati, J. P., McLeod, D. G. R., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., & Srivastava, S. (1994) · PubMed · Cited by 363
Regulation of Progesterone Receptor-Mediated Transcription by Phosphorylation
Denner, L. A., Weigel, N. L., Maxwell, B. L., Schrader, W. T., & O'Malley, B. W. (1990) · Science · doi:10.1126/science.2176746 · Cited by 357
Slamon, D. J. (1998) · Medical Entomology and Zoology · Cited by 347
Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer
Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., & Henderson, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7043 · Cited by 305
Borg, Å., Baldetorp, B., Fernö, M., Killander, D., Olsson, H., Ryden, S., & Sigurdsson, H. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90194-5 · Cited by 246
(1996) · PubMed · Cited by 238
Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., & Ilan, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7263 · Cited by 238
A tyrosine kinase profile of prostate carcinoma.
Robinson, D., He, F., Pretlow, T., & Kung, H. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5958 · Cited by 207
Ben-Levy, R., Paterson, H. F., Marshall, C. J., & Yarden, Y. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06632.x · Cited by 196
Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.
Chazin, V. R., Kaleko, M., Miller, A. D., & Slamon, D. J. (1992) · PubMed · Cited by 170
p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate
Mellon, K., Thompson, S., Charlton, R. G., Marsh, C., Robinson, M., Lane, D. P., Harris, A. L., Horne, C. H. W., & Neal, D. E. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37287-7 · Cited by 169
Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic Carcinoma
Kuhn, E. J., Kurnot, R. A., Sesterhenn, I. A., Chang, E. H., & Moul, J. W. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35799-3 · Cited by 158
Proto-oncogene amplification and human breast tumor phenotype
Adnane, J., Gaudray, P., Simon, M., Simony-Lafontaine, J., Jeanteur, P., & Theillet, C. G. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90028-5 · Cited by 151
Zeillinger, R., Kury, F., Czerwenka, K. F., Kubista, E., Sliutz, G., Knogler, W., Huber, J., Zielinski, C. C., Reiner, G. C. A., & Jakesz, R. (1989) · PubMed · Cited by 150
Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C. L., Michel, K., deKernion, J. B., & Belldegrun, A. S. (1997) · PubMed · Cited by 143
Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer
Sadasivan, R., Morgan, R. J., Jennings, S. B., Austenfeld, M., Veldhuizen, P. J. V., Stephens, R. L., & Noble, M. B. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35413-7 · Cited by 131
A synergistic increase in potency of a multimerized VP16 transcriptional activation domain.
Emami, K. H., & Carey, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05607.x · Cited by 103
Self-citationTranscriptional regulation of prostate kallikrein-like genes by androgen
Wolf, D. A., Schulz, P. J., & Fittler, F. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.5.1376410 · Cited by 98
TAFII250-dependent transcription of cyclin A is directed by ATF activator proteinsPreprint
Wang, E. H., Zou, S., & Tjian, R. (1997) · Genes & Development · doi:10.1101/gad.11.20.2658 · Cited by 86
Research works printed but not linked: 7
- Leitzel, K. et al. Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J. Clin. Oncol. 13, 1129–1135 (1995). · doi:10.1200/jco.1995.13.5.1129
- Ware, J.L., Maygarden, S.J., Koontz, W.W. Jr. & Strom, S.C. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum. Pathol. 22, 254–258 (1991). · doi:10.1016/0046-8177(91)90159-m
- Lyne, J.C. et al. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biological effects on prostate cancer cells in vitro. Cancer J. Sci. Am. 3, 21–30 (1997).
- Ross, J.S. et al. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma. Cancer 79, 2162–2170 ( 1997). · doi:10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u
- Arai, Y., Tatsuhiro, T. & Yoshida, O. c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer. Prostate 30, 195– 201 (1997). · doi:10.1002/(sici)1097-0045(19970215)30:3<195::aid-pros8>3.0.co;2-l
- Romijn, J.C., Verkoelen, C.F. & Schroeder, F.H. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 12, 99–110 (1988). · doi:10.1002/pros.2990120112
- Cobleigh, M.A. et al. Efficacy and safety of HerceptinTM (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherapy for metastatic breast cancer. Progr/Proc. Am. Soc. Clin. Oncol. 17, 97a (1998).
Cited by
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Self-citationAndrogen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Self-citationTargeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
Agus, D. B., Akita, R. W., Fox, W. D., Lewis, G. D., Higgins, B., Pisacane, P. I., Lofgren, J. A., Tindell, C., Evans, D. P., Maiese, K., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00097-1 · Cited by 873
Metadata
- Authors
- Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L.
- Venue
- Nature Medicine
- Published
- 1999-03
- Volume
- 5
- Issue
- 3
- Pages
- 280-285
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/6495
- OpenAlex
- W1580523172
- Cited by
- 980
- References
- 38
- FWCI
- 56.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.